Company Quick10K Filing
Quick10K
Genesis Healthcare
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-12 Regulation FD, Exhibits
8-K 2019-11-07 Earnings, Exhibits
8-K 2019-08-08 Earnings, Regulation FD, Exhibits
8-K 2019-06-05 Shareholder Vote
8-K 2019-05-09 Earnings, Regulation FD, Exhibits
8-K 2019-03-18 Earnings, Regulation FD, Exhibits
8-K 2019-03-11 Officers
8-K 2019-01-31 Other Events, Exhibits
8-K 2018-11-07 Earnings, Regulation FD, Exhibits
8-K 2018-10-31 Other Events
8-K 2018-10-01 Other Events, Exhibits
8-K 2018-08-07 Earnings, Exhibits
8-K 2018-07-31 Other Events
8-K 2018-06-06 Shareholder Vote
8-K 2018-03-14 Regulation FD, Exhibits
8-K 2018-03-06 Enter Agreement, Other Events, Exhibits
8-K 2018-03-01 Other Events, Exhibits
8-K 2018-02-21 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-02-15 Other Events
8-K 2018-01-15 Officers
8-K 2018-01-10 Regulation FD, Exhibits

Genesis Healthcare Financials

-

GEN Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB QTR)

Revenue, Gross Profit, Net Income

Cash Flow ($BB QTR)

Operating, Investing, Financing

Comparables ($MM) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Ryanair Holdings RYAA -0 13,251 8,036 -0 -0 -0 -0 -35
Lingo Media LMDC -0 2 1 -0 -0 -0 -0 -0
Apollo Education APOL 1,005 2,038 966 -0 -0 21 62 686
China Crawfish CACA -0 0 0 0 -0 -0 -0 -0
Mirenco MREO
Granite Real Estate GRP
Weyland Tech WEYL -0 0 1 -0 -0 -0 -0 -0
Baynon BNON -0 0 0 -0 -0 -0 -0 0
Green Planet Bio Engineering GPLB 4 -0 0 -0 -0 -0 -0 4
G-Mes Holdings GMES -0 1 1 0 0 0 0 0
Immune Therapeutics IMUN 36 0 7 0 -0 -4 -4 40
Therapeutic Solutions TSOI 0 0 -0 -0 -0 -0 -0 -0
Blue Sphere BLSP 19 40 -48 -0 0 -4 -4 20
Frontier Digital Media Group FDMG -0 0 0 0 -0 -0 -0 -0
Stem Holdings STEMH -0 11 2 0 -0 -1 -1 -1
MWF Global MWF -0 -0 -0 0 -0 -0 -0 -0
Clean Coal Technologies CCTC -0 3 -2 -0 -0 -0 -0 -3
SpringWorks SWTX
Brighthouse Life Insurance Co of Ny BHNY -0 7,633 6,936 -0 -0 -0 -0 -19
Imine JRVS 9 9 -0 -0 -0 -0 -0 8

Balance Sheet ($MM)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash25234481149683606252475451526551551221431281429997
Accounts Receivable107113122107107109110115124763754759789
Inventory
PP&E4894914954994794834864884924,5044,5304,5554,7244,6754,6864,7264,5734,5314,5424,3524,3534,2024,0123,8723,8641,0981,113
Assets6836856856626436456446506516,0316,1036,1216,0916,0065,9335,8875,7795,6895,5154,9274,7884,7724,5454,3914,2644,7804,643
Accounts Payable219206202234225211224259255233241286259252240235241230
Long-Term Debt4564524464354204194104084129941,0451,0491,2301,1131,1351,1861,1711,1471,1501,1351,0771,1471,1841,2041,2051,2571,251
Liabilities583580579567551551551555556-6,150-6,241-6,294-6,528-6,483-6,432-6,402-6,270-6,237-6,131-5,916-5,872-5,931-5,761-5,665-5,603-5,565-5,439
Stockholders' Equity100104106959294939495-119-138-172-436-477-499-515-490-549-616-989-1,084-1,159-1,217-1,273-1,340-785-796
Income Statement ($MM)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue2192192142122082072072092101,3431,4191,4161,4411,3011,2721,2171,1621,145
Cost of Revenue
Gross Profit
R&D
SG&A
Tax301-51-1-0-16-4-1733-261323-1-11-0
Net Income632-12-3-31-0-113-19-29-265-43-23-2022-51-65-374-89-69-40-58-15-5
Cash Flow ($MM)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating46-22445-612
Cash Investing-2-4658-21-18-203
Cash Financing1-24-92-2387148